Variation at GLCCI1 and FCER2: one step closer to personalized asthma treatment.

Suppr

超能文献

作者信息

Maitland-van der Zee Anke Hilse, Raaijmakers Jan Am

出版信息

Pharmacogenomics. 2012 Feb;13(3):243-5. doi: 10.2217/pgs.11.177.

DOI:10.2217/pgs.11.177

PMID:22304573

Abstract

摘要

相似文献

Variation at GLCCI1 and FCER2: one step closer to personalized asthma treatment.

Pharmacogenomics. 2012 Feb;13(3):243-5. doi: 10.2217/pgs.11.177.

Admixture of beneficial and unfavourable variants of GLCCI1 and FCER2 in Roma samples can implicate different clinical response to corticosteroids.

Mol Biol Rep. 2014 Nov;41(11):7665-9. doi: 10.1007/s11033-014-3659-7. Epub 2014 Aug 5.

FCER2 T2206C variant associated with chronic symptoms and exacerbations in steroid-treated asthmatic children.

Allergy. 2011 Dec;66(12):1546-52. doi: 10.1111/j.1398-9995.2011.02701.x. Epub 2011 Sep 29.

A role of FCER1A and FCER2 polymorphisms in IgE regulation.

Allergy. 2014 Feb;69(2):231-6. doi: 10.1111/all.12336. Epub 2013 Dec 20.

FCER2 T2206C variant associated with FENO levels in asthmatic children using inhaled corticosteroids: The PACMAN study.

Clin Exp Allergy. 2019 Nov;49(11):1429-1436. doi: 10.1111/cea.13460. Epub 2019 Aug 26.

The role of IgE in difficult-to-treat asthma. Of compliance and competence.

Allergy. 2012 Jan;67(1):1-2. doi: 10.1111/j.1398-9995.2011.02740.x.

Int J Immunogenet. 2011 Dec;38(6):533-8. doi: 10.1111/j.1744-313X.2011.01043.x. Epub 2011 Oct 7.

Genetic variations of the FCER2 gene and asthma susceptibility in north Indian children: a case-control study.

Biomarkers. 2013 Dec;18(8):660-7. doi: 10.3109/1354750X.2013.840802. Epub 2013 Oct 8.

Interaction of functional FCER2 promoter polymorphism and phenotype-associated haplotypes.

Tissue Antigens. 2009 Dec;74(6):534-8. doi: 10.1111/j.1399-0039.2009.01360.x. Epub 2009 Oct 21.

FCER2: a pharmacogenetic basis for severe exacerbations in children with asthma.

J Allergy Clin Immunol. 2007 Dec;120(6):1285-91. doi: 10.1016/j.jaci.2007.09.005. Epub 2007 Nov 5.

引用本文的文献

Efficacy and safety of modified Bushen Yiqi formulas (MBYF) as an add-on to formoterol and budesonide in the management of COPD: study protocol for a multicentre, double-blind, placebo-controlled, parallel-group, randomized clinical trial: FB-MBYF Trial.

Trials. 2022 Feb 14;23(1):143. doi: 10.1186/s13063-022-06057-7.

Glucocorticoid-Induced Transcription Factor 1 (GLCCI1) Variant Impacts the Short-Term Response to Intranasal Corticosteroids in Chinese Han Patients with Seasonal Allergic Rhinitis.

Med Sci Monit. 2018 Jul 7;24:4691-4697. doi: 10.12659/MSM.908814.

GLCCI1 rs37973: A potential genetic predictor of therapeutic response to inhaled corticosteroids in Chinese asthma patients.

Medicine (Baltimore). 2017 Dec;96(52):e9442. doi: 10.1097/MD.0000000000009442.

Admixture of beneficial and unfavourable variants of GLCCI1 and FCER2 in Roma samples can implicate different clinical response to corticosteroids.

Mol Biol Rep. 2014 Nov;41(11):7665-9. doi: 10.1007/s11033-014-3659-7. Epub 2014 Aug 5.

Clinically relevant pharmacogenomic testing in pediatric practice.

Clin Pediatr (Phila). 2014 Aug;53(9):831-8. doi: 10.1177/0009922814533186. Epub 2014 May 6.

GLCCI1 rs37973 does not influence treatment response to inhaled corticosteroids in white subjects with asthma.

J Allergy Clin Immunol. 2014 Feb;133(2):587-9. doi: 10.1016/j.jaci.2013.08.024. Epub 2013 Oct 13.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验